Awakn Life Sciences Corp. (OTCMKTS:AWKNF) Short Interest Up 293.9% in October

Awakn Life Sciences Corp. (OTCMKTS:AWKNF) saw a large increase in short interest during the month of October. As of October 15th, there was short interest totalling 44,900 shares, an increase of 293.9% from the September 30th total of 11,400 shares. Based on an average trading volume of 41,800 shares, the short-interest ratio is currently 1.1 days.

Awakn Life Sciences Stock Performance

AWKNF stock remained flat at $0.08 during mid-day trading on Friday. 50 shares of the company’s stock were exchanged, compared to its average volume of 14,679. Awakn Life Sciences has a 12 month low of $0.04 and a 12 month high of $0.26. The company’s fifty day moving average price is $0.08 and its 200 day moving average price is $0.10.

Awakn Life Sciences Company Profile

Awakn Life Sciences Corp., a biotechnology company, engages in the researching, developing, operations, and delivering of psychedelic therapeutics to treat addiction and other mental health conditions in the United Kingdom and Europe. The company has a collaboration agreement with the University of Exeter for exploring the use of ketamine-assisted therapy to treat Severe AUD.